Depoortère, R <br/><br/>
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.  [electronic resource] 

 -  British journal of pharmacology  May 2007 
 - 266-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1188 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjp.0707160  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amnesia--physiopathology<br/>Animals<br/>Antipsychotic Agents--pharmacology<br/>Behavior, Animal--drug effects<br/>Benzofurans--pharmacology<br/>Benzylamines--pharmacology<br/>Cognition Disorders--chemically induced<br/>Cyclopentanes--pharmacology<br/>Dopamine Agonists--pharmacology<br/>Dopamine Antagonists--pharmacology<br/>Dopamine D2 Receptor Antagonists<br/>Dose-Response Relationship, Drug<br/>Male<br/>Models, Animal<br/>Phencyclidine<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Dopamine D3--antagonists & inhibitors<br/>Receptors, Dopamine D4--agonists<br/>Reflex--drug effects<br/>Reflex, Startle--drug effects<br/>Serotonin 5-HT1 Receptor Agonists<br/>Serotonin 5-HT1 Receptor Antagonists<br/>Serotonin Receptor Agonists--pharmacology